CSPC Pharmaceutical Group Limited (FRA:CVG)

Market Cap	7.26B
Revenue (ttm)	3.84B
Net Income (ttm)	572.73M
Shares Out	n/a
EPS (ttm)	0.05
PE Ratio	12.67
Forward PE	11.72
Dividend	0.04 (5.47%)
Ex-Dividend Date	Jun 4, 2025

Volume	n/a
Average Volume	4,965
Open	0.6332
Previous Close	0.6482
Day's Range	0.6332 - 0.6332
52-Week Range	0.5108 - 0.9490
Beta	n/a
RSI	52.59
Earnings Date	May 23, 2025

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, North America, Europe, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic ...

• Industry: Pharmaceutical Preparations
• Founded: 1992
• Employees: 21,400
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CVG

Financial Performance

In 2024, CSPC Pharmaceutical Group's revenue was 29.01 billion, a decrease of -7.76% compared to the previous year's 31.45 billion. Earnings were 4.33 billion, a decrease of -26.31%.

Financial numbers in CNY